Tetra Bio-Pharma Targets Rare Cancers in the United States
Tetra Bio-Pharma Inc. today announced the submission of multiple applications for Orphan Drug Designation for cannabinoids to the U.S. Food and Drug Administration, for the treatment of various forms of rare cancers and ocular diseases.